Adrenocorticotropic activities of eight octadecapeptide analogues related in structure to the N-terminal sequence of ACTH were compared. The extravascular: intravasuclar potency ratios of three peptides, Ser
1-ACTH (1-18)(I), Ser
1-ACTH (1-18) amide (II) and Gly
1-ACTH (1-18) amide (III), were 1/5-1/8, whereas those of five peptides, β-Ala
1-ACTH (1-18) amide (IV), Ibu
1-ACTH (1-18) amide (V), β-Ala
1, Orn
15-ACTH (1-18) amide (VI), Ibu
1, Orn
15-ACTH (1-18) amide (VII), and β-Ala
1, D-Phe
7, Orn
15-ACTH (1-18) amide (VIII), were 1-1/2. In vivo half-lives of the steroidogenic and lipolytic activities of the peptides injected intravenously differed slightly, but the ranking of the peptides for both criteria was the same. The in vitro half-lives of the lipolytic activity of peptides, III, IV and V, incubated with fresh plasma were similar and about a half of that of native ACTH, while those of peptides, VI, VII and VIII were much longer than that of native ACTH. When the peptide III was incubated with a medium containing muscle slices, the half-life in lipolytic activity was about 1/6 of that of native ACTH, but those of other peptides were prolonged in the order III<IV<V=VI<VII=native ACTH. These results indicate that (1) an N-terminal β-Ala or Ibu residue resists aminopeptidase activity, which is higher in tissue than in blood, consequently causing a potentiation of the extravascular potency of the peptide.(2) An ornithine residue in the 15th position of the peptide increases the resistance to endopeptidase activity, which is high in circulating blood, consequently prolonging the half-life in plasma
in vitro. The relationships between
in vitro half-life and two in vitro half-lives in lipolytic activity are considered.
抄録全体を表示